Dozens of drugs made by
Sixty-five different formats and formulations of products including the anesthetic lidocaine; the painkiller morphine; and other basic hospital medicines “may experience continued or new supply disruptions in the near-term,” New York-based Pfizer said Friday in an email to customers. The email lists several different dosages or formulations of at least 32 drugs, plus two sizes of empty glass vials. Forty-six of the products were already in short ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
